Company
Calcilytix Therapeutics, Inc., a BridgeBio company
Calcilytix Therapeutics, Inc., a BridgeBio company has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Encaleret | Phase 3 | Hypoparathyroidism |
Latest
No recent events.
Follow Calcilytix Therapeutics, Inc., a BridgeBio company on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.